We aware that Erlotinib product patent is granted in India as 196774 (537/DEL/1996) and is is subject of many patent infringement cases filed at Delhi high court. Applicant has a divisional application (2018/CHE/2006) of ‘774 patent, which is pending at IPO Chennai.
A communication from Applicant’s attorney states that they wish to withdraw the 2018/CHE/2006 application.
This 2018 application was filed on 02/11/2006 and published on 26/03/2010. This application is subject of pre grant oppositions (filed by two Indian companies).
Note: iPAIRS status has not been changed yet.